MAFLD: How is it different from NAFLD?
The University of Sydney · Royal North Shore Hospital · +8 more institutions
Abstract
"Metabolic dysfunction-associated fatty liver disease (MAFLD)" is the term suggested in 2020 to refer to fatty liver disease related to systemic metabolic dysregulation. The name change from nonalcoholic fatty liver disease (NAFLD) to MAFLD comes with a simple set of criteria to enable easy diagnosis at the bedside for the general medical community, including primary care physicians. Since the introduction of the term, there have been key areas in which the superiority of MAFLD over the traditional NAFLD terminology has been demonstrated, including for the risk of liver and extrahepatic mortality, disease associations, and for identifying high-risk individuals. Additionally, MAFLD has been adopted by a number…
Citation impact
- FWCI
- 55.48
- Percentile
- 100%
- References
- 67
Authors
4- CGCameron GoftonCorresponding
The University of Sydney, Royal North Shore Hospital, Bankstown Lidcombe Hospital, Westmead Hospital, UNSW Sydney, Westmead Institute, Westmead Institute for Medical Research
- YUYadhavan Upendran
The University of Sydney, Westmead Hospital, Westmead Institute, Westmead Institute for Medical Research
- MZMing‐Hua Zheng
Wenzhou University, Wenzhou Medical University, First Affiliated Hospital of Wenzhou Medical University
- JGJacob George
The University of Sydney, Westmead Hospital, Westmead Institute, Westmead Institute for Medical Research
Topics & keywords
- Fatty liver
- Nonalcoholic fatty liver disease
- Medicine
- Disease
- Intensive care medicine
- Internal medicine
- Good health and well-being